Consegna in 90 minuti Gratis da 29,90€ e reso gratis sempre
-
-1%
Trefostil 5% Cutaneous Solution Treatment Of Androgenetic Alopecia 60ml
- Brand: PIERRE FABRE ITALIA SpA
- Product Code: 040777031
- EAN:
- Availability: In Stock (evaso in 24 ore)
- 3 items
for 37,57€ each - 4 items
for 36,81€ each - 5 items
for 36,04€ each
Trefostil * 5% Cutaneous Solution
Treatment of Androgenetic Alopecia
Trefostil is used to treat moderate-intensity androgenetic alopecia in men.
Trefostil is a product for cutaneous use.
A 1 ml dose should be applied to the scalp starting from the center of the affected area, twice a day. Respect the dosage
regardless of the area to be treated. The total dosage should not exceed 2 ml. Apply the product using your fingertips over the entire affected area.
Before and after applying the solution, wash your hands thoroughly. Before application, the hair and scalp must be completely dry.
Do not apply the product to other parts of the body. A treatment of two daily applications is required for a period of two months before the stimulation of hair growth is evident.
Contraindications
- Hypersensitivity to the active substance or to any of the excipients.
- Diseases of the scalp.
- Poor tolerability to the 2% formulation, regardless of symptoms.
Special warnings
In subjects suffering from dermatosis of the scalp, greater percutaneous absorption of minoxidil is possible. Although the occurrence of systemic effects related to minoxidil has not been observed during use of the solution, the possible occurrence of such effects cannot be excluded. As a precautionary measure, the possible appearance of symptoms indicating systemic effects, such as lowering of blood pressure, tachycardia, signs of hydro / sodium retention, should be regularly monitored.
A medical history and clinical examination should be done before using the medicinal product. Patients with known cardiovascular disease or cardiac arrhythmias should contact a physician before using minoxidil. In particular, they should be warned of possible undesirable effects and informed of the possible occurrence of tachycardia, water / sodium retention or weight gain, or other systemic effects which require particular vigilance.
The control must be carried out at the beginning of the treatment and regularly thereafter. Treatment should be discontinued in case of systemic effects or severe dermatological reactions. Due to the risk of hypertrichosis in areas far from the application area, the use of this medicine cannot be justified in women. Minoxidil is not indicated when there is no family history of hair loss, hair loss is sudden and / or patchy, hair loss is due to
childbirth or the reason for hair loss is unknown.
The user should discontinue use of the product and consult a physician if hypotension is detected or if you experience chest pain, rapid heartbeat, fainting or dizziness, sudden unexplained weight gain, swollen hands or feet, or persistent redness or irritation of the scalp.
Pregnancy and breastfeeding
Systemically absorbed minoxidil is excreted in human milk. There are no adequate and well-controlled studies in pregnant women. Animal studies have shown a risk to the fetus at exposure levels that are very high compared to those intended for human exposure. A low, albeit remote, risk of fetal harm is possible in humans.
However, the medicine is not recommended for women
Expiry and retention
Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored. Store in the original package in order to protect from moisture.
Warning: do not use the medicine after the expiry date indicated on the package.
Composition
Buscofenact contains:
Active ingredient: 50 mg of minoxidil
Excipients: Propylene glycol, ethanol (96%), purified water.
Format
60ml bottle.
